SciBase Holding AB (DE:5J30)
FRANKFURT:5J30
5J30 Stock Chart & Stats
€0.04
<€0.01(5.00%)
At close: 4:00 PM EST
€0.04
<€0.01(5.00%)
Day’s Range― - ―
52-Week Range€0.26 - €4.44
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
€33.28M
Enterprise Value€385.71M
Total Cash (Recent Filing)€71.25M
Total Debt (Recent Filing)€23.93M
Price to Earnings (P/E)―
Beta14.14
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-20.94
Shares Outstanding10,225,300
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)18.68
Price to Sales (P/S)3.07
P/FCF Ratio-1.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.76
Revenue Forecast (FY)€6.40M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthConsistent multi-year revenue growth shows expanding clinical adoption of SciBase’s diagnostic platform, improving prospects for operating leverage. Over 2-6 months this trend supports scaled commercialization and higher installed-base utilization if execution continues.
Recurring Consumable Revenue ModelA product model that pairs device placements with usage-linked consumables generates repeatable, higher-margin revenue. This creates durable unit economics and predictable volume growth as installed systems ramp, supporting long-term margin sustainability if test volumes rise.
Manageable Leverage / Positive EquityModerate debt relative to equity and positive net assets reduce immediate solvency risk versus highly leveraged peers. This balance sheet position gives the company structural flexibility to raise capital or invest in commercialization without being overburdened by interest costs.
Bears Say
Large Operating And Net LossesVery wide negative operating and net margins indicate the cost base far exceeds current revenue, a structural profitability issue. Without sustained revenue scale or cost restructuring, losses will persist, undermining returns and requiring ongoing external support.
Deep Cash BurnMaterial negative operating and free cash flow reflect a cash-burning growth profile that is unlikely to self-fund near-term expansion. Persistent burn raises the structural need for financing, increasing dilution risk and constraining long-term investment flexibility.
Volatile Equity / Financing RiskHistorically low and volatile equity levels, coupled with ongoing losses, increase the probability of future capital raises. This structural financing vulnerability can dilute shareholders and may force unfavorable funding terms that constrain strategic choices.
5J30 FAQ
What was SciBase Holding AB’s price range in the past 12 months?
SciBase Holding AB lowest stock price was €0.26 and its highest was €4.44 in the past 12 months.
What is SciBase Holding AB’s market cap?
SciBase Holding AB’s market cap is €33.28M.
When is SciBase Holding AB’s upcoming earnings report date?
SciBase Holding AB’s upcoming earnings report date is Aug 19, 2026 which is in 60 days.
How were SciBase Holding AB’s earnings last quarter?
SciBase Holding AB released its earnings results on May 07, 2026. The company reported -€0.274 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.274.
Is SciBase Holding AB overvalued?
According to Wall Street analysts SciBase Holding AB’s price is currently Overvalued.
Does SciBase Holding AB pay dividends?
SciBase Holding AB does not currently pay dividends.
What is SciBase Holding AB’s EPS estimate?
SciBase Holding AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SciBase Holding AB have?
SciBase Holding AB has 10,225,300 shares outstanding.
What happened to SciBase Holding AB’s price movement after its last earnings report?
SciBase Holding AB reported an EPS of -€0.274 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.125%.
Which hedge fund is a major shareholder of SciBase Holding AB?
Currently, no hedge funds are holding shares in DE:5J30
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SciBase Holding AB
SciBase Holding AB (publ), a medical technology firm founded in 1998 and headquartered in Sundbyberg, Sweden, specializes in the global development and distribution of instruments for diagnosing skin cancer and other dermatological issues. Their key offerings, Nevisense and Nevisense Go, comprise a point-of-care platform designed for the detection of melanoma and non-melanoma skin cancers, as well as for evaluating skin barrier function. The company also maintains a collaborative agreement with the Advanced Dermatology and Cosmetic Surgery (ADCS) group.
Technical Analysis
Clinical Laserthermia Systems AB Class B
―
Luxbright AB
―
Arcoma AB
―
Neola Medical AB
―
Iconovo AB
―